Thursday, January 31, 2019 11:12:38 PM
Marzan my friend, it is all in my opinion. I hope you are right and I am wrong. Happy to eat crow. My purpose is to express an opinion and candidly, a lot of long posters are pollyanna-ish. I don't see this investment thru rose coloured glasses and I am not looking for what I think are unrealistic share prices. I would be happy with a couple of bucks considering my cost level and number of shares held.
If you read my posts carefully, I am quite positive about the science and the ultimate success of the trial. But to reach dollar levels in the share price, NWBO has to hit a double grand slam in the long tail because I believe the primary/secondary end points won't get them there. Look, a couple of bucks above where we are now is an 8x premium. Not so bad. In fact LP and friends have enough shares that even at this price they make out like bandits. But $10 or $15 bucks? Hmmmmmm, probably not in my lifetime and certainly not counting on it. Maybe its just me. Anyway, GLTY.
Regards,
U
If you read my posts carefully, I am quite positive about the science and the ultimate success of the trial. But to reach dollar levels in the share price, NWBO has to hit a double grand slam in the long tail because I believe the primary/secondary end points won't get them there. Look, a couple of bucks above where we are now is an 8x premium. Not so bad. In fact LP and friends have enough shares that even at this price they make out like bandits. But $10 or $15 bucks? Hmmmmmm, probably not in my lifetime and certainly not counting on it. Maybe its just me. Anyway, GLTY.
Regards,
U
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
